Optimizing heroin-assisted treatment (HAT): Assessment of the contribution of direct ethanol metabolites in identifying hazardous and harmful alcohol use

Drug and Alcohol Dependence

Volumn 115, Issue 1-2, 2011, Pages 57-61

  Wurst, Friedrich M ^a   Thon, Natasha ^a   Yegles, Michel ^b   Halter, Claudia ^c   Weinmann, Wolfgang ^c   Laskowska, Barbara ^d   Strasser, Johannes ^d   Skipper, Gregory ^e   Wiesbeck, Gerhard A ^d   Dürsteler MacFarland, Kenneth ^d,f  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF BASEL   (Switzerland)

^e Alabama Physician Health Program   (United States)

^f UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

Alcohol; Ethyl glucuronide; Ethyl sulphate; Hepatitis C; Heroin assisted treatment; Opioid dependence

Indexed keywords

ALCOHOL DERIVATIVE; DIAMORPHINE; ETHYL GLUCURONIDE; ETHYL SULFATE; METHADONE; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; HAIR LEVEL; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; SELF REPORT; SWITZERLAND; URINE LEVEL;

ADULT; ALCOHOL DRINKING; ETHANOL; FEMALE; GLUCURONATES; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE TREATMENT CENTERS; SULFURIC ACID ESTERS; YOUNG ADULT;

EID: 79955548742     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.10.020     Document Type: Article

References (41)

1. Caudai C., Padula M.G., Bastianoni I., Valensin P.E., Shyamala V., Han J., Boggiano C.A., Almi P. Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons. Infection 1998, 26:151-154.
2. Daiter J., Teplin D., Varenbut M., Worster A., Raz B. Diagnostic value of self-report of alcohol use in patients enrolled in a methadone maintenance treatment program (MMTP). J. Addict. Dis. 2007, 26:87-92.
3. Darke S., Ross J. Suicide among heroin users: rates, risk factors and methods. Addiction 2002, 97:1383-1394.
4. Dresen S., Weinmann W., Wurst F.M. Forensic confirmatory analysis of ethyl sulfate - a new marker for alcohol consumption - by liquid-chromatography/electrospray ionization/tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 2004, 15:1644-1648.
5. European Monitoring Centre for Drugs, a.D.A. Annual Report 2008-The State of the Drugs Problem in Europe 2008.
6. Fagerström K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict. Behav. 1978, 3:235-241.
7. Gossop M., Browne N., Stewart D., Marsden J. Alcohol use outcomes and heavy drinking at 4-5 years among a treatment sample of drug misusers. J. Subst. Abuse Treat. 2003, 25:135-143.
8. Guy W. Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology, Revised National Institute of Mental Health 1976.
9. Haasen C., Eiroa-Orosa F.J., Verthein U., Soyka M., Dilg C., Schafer I., Reimer J. Effects of heroin-assisted treatment on alcohol consumption: findings of the German randomized controlled trial. Alcohol 2009, 43:259-264.
10. Haasen C., Verthein U., Degkwitz P., Berger J., Krausz M., Naber D. Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br. J. Psychiatry 2007, 191:55-62.
11. Halter C.C., Dresen S., Auwaerter V., Wurst F.M., Weinmann W. Kinetics in serum and urinary excretion of ethyl sulfate and ethyl glucuronide after medium dose ethanol intake. Int. J. Legal Med. 2008, 122:123-128.
12. Hannuksela M.L., Liisanantti M.K., Nissinen A.E., Savolainen M.J. Biochemical markers of alcoholism. Clin. Chem. Lab. Med. 2007, 45:953-961.
13. Helander A., Beck O. Mass spectrometric identification of ethyl sulfate as an ethanol metabolite in humans. Clin. Chem. 2004, 50:936-937.
14. Høiseth G., Morini L., Polettini A., Christophersen A., Mørland J. Blood kinetics of ethyl glucuronide and ethyl sulphate in heavy drinkers during alcohol detoxification. Forensic Sci. Int. 2009, 188:52-56.
15. Kerekes I., Yegles M., Grimm U., Wennig R. Ethyl glucuronide determination: head hair versus non-head hair. Alcohol Alcohol. 2009, 44:62-66.
16. Kreek M.J., Vocci F.J. History and current status of opioid maintenance treatments: blending conference session. J. Subst. Abuse Treat. 2002, 23:93-105.
17. Laberke P.J., Bartsch C. Trends in methadone-related deaths in Zurich. Int. J. Legal Med. 2010, 2010 Mar 27 (Epub ahead of print).
18. Li X., Sun H., Purl A., Marsh D.C., Anis A.H. Factors associated with pretreatment and treatment dropouts among clients admitted to medical withdrawal management. J. Addict. Dis. 2007, 26:77-85.
19. Lintzeris N. Prescription of heroin for the management of heroin dependence: current status. CNS Drugs 2009, 23:463-476.
20. Luborsky L. Clinicians' judgments of mental health. Arch. Gen. Psychiatry 1962, 7:407-417.
21. National Institutes of Health Consensus Development Conference Panel Statement Management of hepatitis C. Hepatology 1997, 26:2-10.
22. NIAAA National Advisory Council, 2004. (accessed September 23, 2009). http://pubs.niaaa.nih.gov/publications/Newsletter/winter2004/Newsletter_Number3.pdf.
23. Nyamathi A., Cohen A., Marfisee M., Shoptaw S., Greengold B., de Castro V., George D., Leake B. Correlates of alcohol use among methadone-maintained adults. Drug Alcohol Depend. 2009, 101:124-127.
24. Oviedo-Joekes E., Brissette S., Marsh D.C., Lauzon P., Guh D., Anis A., Schechter M.T. Diacetylmorphine versus methadone for the treatment of opioid addiction. N. Engl. J. Med. 2009, 361:777-786.
25. Perneger T.V., Giner F., del Rio M., Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998, 317:13-18.
26. Peters M.G., Terrault N.A. Alcohol use and hepatitis C. Hepatology 2002, 36:220-225.
27. Pragst F., Yegles M. Alcohol markers in hair. Analytical and Practical Aspects Drug Testing in Hair 2007, 287-324. CRC Press, Taylor & Francis, Boca Raton, London, New York. P. Kintz (Ed.).
28. Rowan-Szal G.A., Chatham L.R., Simpson D.D. Importance of identifying cocaine and alcohol dependent methadone clients. Am. J. Addict. 2000, 9:38-50.
29. Ryder N., Cullen W., Barry J., Bury G., Keenan E., Smyth B.P. Prevalence of problem alcohol use among patients attending primary care for methadone treatment. BMC Fam. Pract. 2009, 10:42.
30. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993, 88:791-804.
31. Skipsey K., Burleson J.A., Kranzler H.R. Utility of the AUDIT for identification of hazardous or harmful drinking in drug-dependent patients. Drug Alcohol Depend. 1997, 45:157-163.
32. Teplin D., Raz B., Daiter J., Varenbut M., Plater-Zyberk C. Screening for alcohol use patterns among methadone maintenance patients. Am. J. Drug Alcohol Abuse 2007, 33:179-183.
33. van den Brink W., Hendriks V.M., Blanken P., Koeter M.W., van Zwieten B.J., van Ree J.M. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 2003, 327:310.
34. Vocci F.J., Acri J., Elkashef A. Medication development for addictive disorders: the state of the science. Am. J. Psychiatry 2005, 162:1432-1440.
35. Ward J., Hall W., Mattick R.P. Role of maintenance treatment in opioid dependence. Lancet 1999, 353:221-226.
36. Warner-Smith M., Darke S., Lynskey M., Hall W. Heroin overdose: causes and consequences. Addiction 2001, 96:1113-1125.
37. Weinmann W., Schaefer P., Thierauf A., Schreiber A., Wurst F.M. Confirmatory analysis of ethylglucuronide in urine by liquid-chromatography/electrospray-tandem-mass-spectrometry. J. Am. Soc. Mass Spectrom. 2004, 15:188-193.
38. Wiley T.E., McCarthy M., Breidi L., Layden T.J. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998, 28:805-809.
39. Wurst F.M., Dürsteler-MacFarland K.M., Auwaerter V., Ergovic S., Thon N., Yegles M., Halter C., Weinmann W., Wiesbeck G.A. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports. Alcohol. Clin. Exp. Res. 2008, 32:1552-1557.
40. Wurst F.M., Dresen S., Allen J.P., Wiesbeck G., Graf M., Weinmann W. Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. Addiction 2006, 101:204-211.
41. Wurst F.M., Skipper G.E., Weinmann W. Ethyl glucuronide-the direct ethanol metabolite on the threshold from science to routine use. Addiction 2003, 98:51-61.